A citation-based method for searching scientific literature

Simon J Hogg, Paul A Beavis, Mark A Dawson, Ricky W Johnstone. Nat Rev Drug Discov 2020
Times Cited: 77







List of co-cited articles
611 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
11

Epigenetic therapy in immune-oncology.
Peter A Jones, Hitoshi Ohtani, Ankur Chakravarthy, Daniel D De Carvalho. Nat Rev Cancer 2019
204
11

Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy.
Dongjun Peng, Ilona Kryczek, Nisha Nagarsheth, Lili Zhao, Shuang Wei, Weimin Wang, Yuqing Sun, Ende Zhao, Linda Vatan, Wojciech Szeliga,[...]. Nature 2015
612
10

TIMER2.0 for analysis of tumor-infiltrating immune cells.
Taiwen Li, Jingxin Fu, Zexian Zeng, David Cohen, Jing Li, Qianming Chen, Bo Li, X Shirley Liu. Nucleic Acids Res 2020
876
10

Regulation of chromatin by histone modifications.
Andrew J Bannister, Tony Kouzarides. Cell Res 2011
9

Cancer epigenetics: from mechanism to therapy.
Mark A Dawson, Tony Kouzarides. Cell 2012
9

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.
Padmanee Sharma, Siwen Hu-Lieskovan, Jennifer A Wargo, Antoni Ribas. Cell 2017
9

LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade.
Wanqiang Sheng, Martin W LaFleur, Thao H Nguyen, Sujun Chen, Ankur Chakravarthy, Jake Ryan Conway, Ying Li, Hao Chen, Henry Yang, Pang-Hung Hsu,[...]. Cell 2018
263
7

GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis.
Zefang Tang, Boxi Kang, Chenwei Li, Tianxiang Chen, Zemin Zhang. Nucleic Acids Res 2019
7

HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade.
David M Woods, Andressa L Sodré, Alejandro Villagra, Amod Sarnaik, Eduardo M Sotomayor, Jeffrey Weber. Cancer Immunol Res 2015
234
6

HDACs and HDAC Inhibitors in Cancer Development and Therapy.
Yixuan Li, Edward Seto. Cold Spring Harb Perspect Med 2016
483
6

New and emerging HDAC inhibitors for cancer treatment.
Alison C West, Ricky W Johnstone. J Clin Invest 2014
889
6

EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation.
Wendy Béguelin, Relja Popovic, Matt Teater, Yanwen Jiang, Karen L Bunting, Monica Rosen, Hao Shen, Shao Ning Yang, Ling Wang, Teresa Ezponda,[...]. Cancer Cell 2013
526
6

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.
Sanjeev Mariathasan, Shannon J Turley, Dorothee Nickles, Alessandra Castiglioni, Kobe Yuen, Yulei Wang, Edward E Kadel, Hartmut Koeppen, Jillian L Astarita, Rafael Cubas,[...]. Nature 2018
6

Oncology meets immunology: the cancer-immunity cycle.
Daniel S Chen, Ira Mellman. Immunity 2013
6

Epidrugs: targeting epigenetic marks in cancer treatment.
Cristiana Libardi Miranda Furtado, Maria Claudia Dos Santos Luciano, Renan Da Silva Santos, Gilvan Pessoa Furtado, Manoel Odorico Moraes, Claudia Pessoa. Epigenetics 2019
67
7

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.
Michael I Love, Wolfgang Huber, Simon Anders. Genome Biol 2014
6

Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade.
Ye Qin, Shauna N Vasilatos, Lin Chen, Hao Wu, Zhishen Cao, Yumei Fu, Min Huang, Anda M Vlad, Binfeng Lu, Steffi Oesterreich,[...]. Oncogene 2019
71
7

DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts.
David Roulois, Helen Loo Yau, Rajat Singhania, Yadong Wang, Arnavaz Danesh, Shu Yi Shen, Han Han, Gangning Liang, Peter A Jones, Trevor J Pugh,[...]. Cell 2015
687
6

Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapy.
Sangeeta Goswami, Irina Apostolou, Jan Zhang, Jill Skepner, Swetha Anandhan, Xuejun Zhang, Liangwen Xiong, Patrick Trojer, Ana Aparicio, Sumit K Subudhi,[...]. J Clin Invest 2018
114
6

An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer.
Marian L Burr, Christina E Sparbier, Kah Lok Chan, Yih-Chih Chan, Ariena Kersbergen, Enid Y N Lam, Elizabeth Azidis-Yates, Dane Vassiliadis, Charles C Bell, Omer Gilan,[...]. Cancer Cell 2019
186
6

Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression.
Cristina Segovia, Edurne San José-Enériz, Ester Munera-Maravilla, Mónica Martínez-Fernández, Leire Garate, Estíbaliz Miranda, Amaia Vilas-Zornoza, Iris Lodewijk, Carolina Rubio, Carmen Segrelles,[...]. Nat Med 2019
76
6

Cancer Epigenetics, Tumor Immunity, and Immunotherapy.
Jian Cao, Qin Yan. Trends Cancer 2020
62
8

The emerging role of epigenetic therapeutics in immuno-oncology.
Michael J Topper, Michelle Vaz, Kristen A Marrone, Julie R Brahmer, Stephen B Baylin. Nat Rev Clin Oncol 2020
120
6

clusterProfiler: an R package for comparing biological themes among gene clusters.
Guangchuang Yu, Li-Gen Wang, Yanyan Han, Qing-Yu He. OMICS 2012
6

UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.
Darshan S Chandrashekar, Bhuwan Bashel, Sai Akshaya Hodigere Balasubramanya, Chad J Creighton, Israel Ponce-Rodriguez, Balabhadrapatruni V S K Chakravarthi, Sooryanarayana Varambally. Neoplasia 2017
6

Metabolic regulation of gene expression by histone lactylation.
Di Zhang, Zhanyun Tang, He Huang, Guolin Zhou, Chang Cui, Yejing Weng, Wenchao Liu, Sunjoo Kim, Sangkyu Lee, Mathew Perez-Neut,[...]. Nature 2019
473
5

Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
Loren M Lasko, Clarissa G Jakob, Rohinton P Edalji, Wei Qiu, Debra Montgomery, Enrico L Digiammarino, T Matt Hansen, Roberto M Risi, Robin Frey, Vlasios Manaves,[...]. Nature 2017
294
5

Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents.
H Yang, C Bueso-Ramos, C DiNardo, M R Estecio, M Davanlou, Q-R Geng, Z Fang, M Nguyen, S Pierce, Y Wei,[...]. Leukemia 2014
443
5

Inactivating mutations of acetyltransferase genes in B-cell lymphoma.
Laura Pasqualucci, David Dominguez-Sola, Annalisa Chiarenza, Giulia Fabbri, Adina Grunn, Vladimir Trifonov, Lawryn H Kasper, Stephanie Lerach, Hongyan Tang, Jing Ma,[...]. Nature 2011
616
5

Role of TET enzymes in DNA methylation, development, and cancer.
Kasper Dindler Rasmussen, Kristian Helin. Genes Dev 2016
495
5

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.
Ryan D Morin, Nathalie A Johnson, Tesa M Severson, Andrew J Mungall, Jianghong An, Rodrigo Goya, Jessica E Paul, Merrill Boyle, Bruce W Woolcock, Florian Kuchenbauer,[...]. Nat Genet 2010
5

The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development.
Ana Ortega-Molina, Isaac W Boss, Andres Canela, Heng Pan, Yanwen Jiang, Chunying Zhao, Man Jiang, Deqing Hu, Xabier Agirre, Itamar Niesvizky,[...]. Nat Med 2015
241
5

TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis.
Pilar M Dominguez, Hussein Ghamlouch, Wojciech Rosikiewicz, Parveen Kumar, Wendy Béguelin, Lorena Fontán, Martín A Rivas, Patrycja Pawlikowska, Marine Armand, Enguerran Mouly,[...]. Cancer Discov 2018
76
5


BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression.
Hengrui Zhu, Fee Bengsch, Nikolaos Svoronos, Melanie R Rutkowski, Benjamin G Bitler, Michael J Allegrezza, Yuhki Yokoyama, Andrew V Kossenkov, James E Bradner, Jose R Conejo-Garcia,[...]. Cell Rep 2016
212
5

Translating the histone code.
T Jenuwein, C D Allis. Science 2001
5



DNA methylation and cancer.
Marta Kulis, Manel Esteller. Adv Genet 2010
825
5

Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1.
Mamta Tahiliani, Kian Peng Koh, Yinghua Shen, William A Pastor, Hozefa Bandukwala, Yevgeny Brudno, Suneet Agarwal, Lakshminarayan M Iyer, David R Liu, L Aravind,[...]. Science 2009
5

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages.
Jennifer L Guerriero, Alaba Sotayo, Holly E Ponichtera, Jessica A Castrillon, Alexandra L Pourzia, Sara Schad, Shawn F Johnson, Ruben D Carrasco, Suzan Lazo, Roderick T Bronson,[...]. Nature 2017
289
5

Macrophages as regulators of tumour immunity and immunotherapy.
David G DeNardo, Brian Ruffell. Nat Rev Immunol 2019
603
5

Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells.
Javier Rodríguez-Ubreva, Francesc Català-Moll, Nataša Obermajer, Damiana Álvarez-Errico, Ricardo N Ramirez, Carlos Company, Roser Vento-Tormo, Gema Moreno-Bueno, Robert P Edwards, Ali Mortazavi,[...]. Cell Rep 2017
73
5

NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control.
Jan P Böttcher, Eduardo Bonavita, Probir Chakravarty, Hanna Blees, Mar Cabeza-Cabrerizo, Stefano Sammicheli, Neil C Rogers, Erik Sahai, Santiago Zelenay, Caetano Reis e Sousa. Cell 2018
673
5

Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.
Terence C S Ho, Alex H Y Chan, A Ganesan. J Med Chem 2020
125
5

Epigenetic Therapies for Cancer.
Susan E Bates. N Engl J Med 2020
122
5

CSF-1R inhibition alters macrophage polarization and blocks glioma progression.
Stephanie M Pyonteck, Leila Akkari, Alberto J Schuhmacher, Robert L Bowman, Lisa Sevenich, Daniela F Quail, Oakley C Olson, Marsha L Quick, Jason T Huse, Virginia Teijeiro,[...]. Nat Med 2013
5


Combining Epigenetic and Immunotherapy to Combat Cancer.
Katherine B Chiappinelli, Cynthia A Zahnow, Nita Ahuja, Stephen B Baylin. Cancer Res 2016
177
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.